Kovack Advisors’s Nexalin Technology NXL Stock Holding History

Kovack Advisors’s Portfolio NXL Stock Details NXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.04K	Sell	22,325 -1,000	-4%	-$411	﹤0.01%	1067
2026 Q1	$8.2K	Hold	23,325	–	–	﹤0.01%	1009
2025 Q4	$13K	Buy	23,325 +13,275	+132%	+$14.9K	﹤0.01%	1011
2025 Q3	$9.22K	Hold	10,050	–	–	﹤0.01%	609
2025 Q2	$9.93K	Buy	+10,050	New	+$14.1K	﹤0.01%	617

Other funds holding NXL

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Kovack Advisors's NXL Position: Q2 2026 in Review

Kovack Advisors reduced its Nexalin Technology (NXL) stake by 4.3% in Q2 2026, selling an estimated $411 and leaving 22,325 shares worth $8.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1067.

Kovack Advisors first reported a position in NXL in Q2 2025 and has held it in 5 quarters since. The position peaked at $13K in Q4 2025. 2 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

Kovack Advisors held 22,325 shares of Nexalin Technology worth $8.04K as of Q2 2026.
Kovack Advisors sold 1,000 Nexalin Technology shares in Q2 2026, an estimated $411.
Nexalin Technology made up ﹤0.01% of Kovack Advisors's portfolio in Q2 2026, its #1067 holding.
Kovack Advisors first reported a position in Nexalin Technology in Q2 2025 and has held it in 5 quarters since.
Kovack Advisors's Nexalin Technology position peaked at $13K in Q4 2025.
2 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.